메뉴 건너뛰기




Volumn 12, Issue 1, 2009, Pages 80-87

Effects of drospirenone on cardiovascular markers in human aortic endothelial cells

Author keywords

Cardiovascular marker; Coronary aortic endothelial cells; Drospirenone; Medroxyprogesterone acetate; Progesterone

Indexed keywords

ALDOSTERONE; DROSPIRENONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE; PROMEGESTONE; SPIRONOLACTONE; VASCULAR CELL ADHESION MOLECULE 1;

EID: 58149164712     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130802403994     Document Type: Article
Times cited : (19)

References (25)
  • 1
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women
    • Writing Group for the Women's Health Initiative Investigators
    • Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33
    • (2002) JAMA , vol.288 , pp. 321-333
  • 2
    • 1842867053 scopus 로고    scopus 로고
    • Effects of conjugated equine estrogen in postmenopausal women with hysterectomy
    • The Women's Health Initiative Steering Committee
    • The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004;291:1701-12
    • (2004) JAMA , vol.291 , pp. 1701-1712
  • 3
    • 2342563102 scopus 로고    scopus 로고
    • Oelkers W. Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol Cell Endocrinol 2004;217:255-61
    • Oelkers W. Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol Cell Endocrinol 2004;217:255-61
  • 4
    • 33646262887 scopus 로고    scopus 로고
    • Epidemiology of coronary heart disease in women
    • Khaw KT. Epidemiology of coronary heart disease in women. Heart 2006;92:2-4
    • (2006) Heart , vol.92 , pp. 2-4
    • Khaw, K.T.1
  • 5
    • 0032693599 scopus 로고    scopus 로고
    • Atherosclerosis is an inflammatory disease
    • Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:S419-20
    • (1999) Am Heart J , vol.138
    • Ross, R.1
  • 6
    • 0032981919 scopus 로고    scopus 로고
    • Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women
    • van Baal WM, Kenemans P, Emeis JJ, et al. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women. Fertil Steril 1999;71:663-70
    • (1999) Fertil Steril , vol.71 , pp. 663-670
    • van Baal, W.M.1    Kenemans, P.2    Emeis, J.J.3
  • 7
    • 0343632564 scopus 로고    scopus 로고
    • Scarabin PY, Alhenc-Gelas M, Oger E, Plu-Bureau G. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women - a randomised controlled trial. Thromb Haemost 1999;81:673-5
    • Scarabin PY, Alhenc-Gelas M, Oger E, Plu-Bureau G. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women - a randomised controlled trial. Thromb Haemost 1999;81:673-5
  • 8
    • 0032739824 scopus 로고    scopus 로고
    • Short-term hormone replacement therapy: Reduced plasma levels of soluble adhesion molecules
    • Van Baal WM, Emeis JJ, Kenemans P, et al. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules. Eur J Clin Invest 1999;29:913-21
    • (1999) Eur J Clin Invest , vol.29 , pp. 913-921
    • Van Baal, W.M.1    Emeis, J.J.2    Kenemans, P.3
  • 9
    • 0036890084 scopus 로고    scopus 로고
    • The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: A randomized, controlled trial
    • Stork S, von Schacky C, Angerer P. The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial. Atherosclerosis 2002;165:301-7
    • (2002) Atherosclerosis , vol.165 , pp. 301-307
    • Stork, S.1    von Schacky, C.2    Angerer, P.3
  • 10
    • 0034050917 scopus 로고    scopus 로고
    • Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease
    • Seljeflot I, Arnesen H, Hofstad AE, Os I. Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease. Thromb Haemost 2000;83:944-8
    • (2000) Thromb Haemost , vol.83 , pp. 944-948
    • Seljeflot, I.1    Arnesen, H.2    Hofstad, A.E.3    Os, I.4
  • 11
    • 0034105495 scopus 로고    scopus 로고
    • Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease
    • Sbarouni E, Kroupis C, Kyriakides ZS, Koniavitou K, Kremastinos DT. Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease. Eur Heart J 2000;21:975-80
    • (2000) Eur Heart J , vol.21 , pp. 975-980
    • Sbarouni, E.1    Kroupis, C.2    Kyriakides, Z.S.3    Koniavitou, K.4    Kremastinos, D.T.5
  • 12
    • 0033578463 scopus 로고    scopus 로고
    • Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
    • Cushman M, Legault C, Barrett-Connor E, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999;100:717-22
    • (1999) Circulation , vol.100 , pp. 717-722
    • Cushman, M.1    Legault, C.2    Barrett-Connor, E.3
  • 13
    • 0034749552 scopus 로고    scopus 로고
    • Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels
    • Koh KK, Son JW, Ahn JY, et al. Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels. Int J Cardiol 2001;81:43-50
    • (2001) Int J Cardiol , vol.81 , pp. 43-50
    • Koh, K.K.1    Son, J.W.2    Ahn, J.Y.3
  • 14
    • 0037083957 scopus 로고    scopus 로고
    • The effect of 17beta-estradiol on MCP-1 serum levels in postmenopausal women
    • Stork S, Baumann K, von Schacky C, Angerer P. The effect of 17beta-estradiol on MCP-1 serum levels in postmenopausal women. Cardiovasc Res 2002;53:642-9
    • (2002) Cardiovasc Res , vol.53 , pp. 642-649
    • Stork, S.1    Baumann, K.2    von Schacky, C.3    Angerer, P.4
  • 15
    • 20744446634 scopus 로고    scopus 로고
    • Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women
    • Sumino H, Ichikawa S, Ohyama Y, et al. Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women. J Cardiol 2005;96:148-53
    • (2005) J Cardiol , vol.96 , pp. 148-153
    • Sumino, H.1    Ichikawa, S.2    Ohyama, Y.3
  • 16
    • 0034660437 scopus 로고    scopus 로고
    • Plasminogen-activator inhibitor type 1 and coronary artery disease
    • Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000;342:1792-801
    • (2000) N Engl J Med , vol.342 , pp. 1792-1801
    • Kohler, H.P.1    Grant, P.J.2
  • 17
    • 0029162314 scopus 로고
    • The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones
    • Sobel MI, Winkel CA, Macy LB, Liao P, Bjornsson TD. The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones. Am J Obstet Gynecol 1995;173:801-8
    • (1995) Am J Obstet Gynecol , vol.173 , pp. 801-808
    • Sobel, M.I.1    Winkel, C.A.2    Macy, L.B.3    Liao, P.4    Bjornsson, T.D.5
  • 18
    • 0036304871 scopus 로고    scopus 로고
    • Medroxyprogesterone acetate versus norethisterone: Effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures
    • Mueck AO, Seeger H, Wallwiener D. Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures. Menopause 2002;9:273-81
    • (2002) Menopause , vol.9 , pp. 273-281
    • Mueck, A.O.1    Seeger, H.2    Wallwiener, D.3
  • 19
    • 0030784934 scopus 로고    scopus 로고
    • The effect of transdermal oestradiol and oral progestogens on haemostasis variables
    • Kroon UB, Tengborn L, Rita H, Backstrom AC. The effect of transdermal oestradiol and oral progestogens on haemostasis variables. Br J Obstet Gynaecol 1997;104:32-7
    • (1997) Br J Obstet Gynaecol , vol.104 , pp. 32-37
    • Kroon, U.B.1    Tengborn, L.2    Rita, H.3    Backstrom, A.C.4
  • 20
    • 0031443428 scopus 로고    scopus 로고
    • Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 1997;17:3071-8
    • Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 1997;17:3071-8
  • 21
    • 0035901620 scopus 로고    scopus 로고
    • Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women
    • Koh KK, Jin DK, Yang SH, et al. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women. Circulation 2001;103:1961-6
    • (2001) Circulation , vol.103 , pp. 1961-1966
    • Koh, K.K.1    Jin, D.K.2    Yang, S.H.3
  • 22
    • 0034101946 scopus 로고    scopus 로고
    • Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis
    • Teede HJ, McGrath BP, Smolich JJ, et al. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. Arterioscler Thromb Vasc Biol 2000;20:1404-9
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 1404-1409
    • Teede, H.J.1    McGrath, B.P.2    Smolich, J.J.3
  • 23
    • 0034950083 scopus 로고    scopus 로고
    • Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism
    • Lobo RA, Bush T, Carr BR, Pickar JH. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril 2001;76:13-24
    • (2001) Fertil Steril , vol.76 , pp. 13-24
    • Lobo, R.A.1    Bush, T.2    Carr, B.R.3    Pickar, J.H.4
  • 25
    • 34748878206 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women
    • Karara AH, Hanes V, Alonso A, et al. Pharmacokinetics and pharmacodynamics of drospirenone-estradiol combination hormone therapy product coadministered with hydrochlorothiazide in hypertensive postmenopausal women. J Clin Pharmacol 2007;47:1292-302
    • (2007) J Clin Pharmacol , vol.47 , pp. 1292-1302
    • Karara, A.H.1    Hanes, V.2    Alonso, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.